BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 35281015)

  • 1. The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment.
    Xue C; Gu X; Bao Z; Su Y; Lu J; Li L
    Front Immunol; 2022; 13():847728. PubMed ID: 35281015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential.
    Han Q; Wang M; Dong X; Wei F; Luo Y; Sun X
    Front Immunol; 2022; 13():985815. PubMed ID: 36300115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncoding RNA as therapeutic targets for hepatocellular carcinoma.
    George J; Patel T
    Semin Liver Dis; 2015 Feb; 35(1):63-74. PubMed ID: 25632936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
    Hou W; Bonkovsky HL
    World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects of Noncoding RNAs in Hepatocellular Carcinoma.
    Zhou H; Xu Q; Ni C; Ye S; Xu X; Hu X; Jiang J; Hong Y; Huang D; Yang L
    Biomed Res Int; 2018; 2018():6579436. PubMed ID: 30148169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of noncoding RNAs in the tumor microenvironment of hepatocellular carcinoma.
    Yang Q; Tian H; Guo Z; Ma Z; Wang G
    Acta Biochim Biophys Sin (Shanghai); 2023 Nov; 55(11):1697-1706. PubMed ID: 37867435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis.
    Tian Y; Zhang M; Liu LX; Wang ZC; Liu B; Huang Y; Wang X; Ling YZ; Wang F; Feng X; Tu Y
    Front Immunol; 2024; 15():1400744. PubMed ID: 38799446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decoding hepatocarcinogenesis from a noncoding RNAs perspective.
    El-Aziz MKA; Dawoud A; Kiriacos CJ; Fahmy SA; Hamdy NM; Youness RA
    J Cell Physiol; 2023 Sep; 238(9):1982-2009. PubMed ID: 37450612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncoding RNAs as sensors of tumor microenvironmental stress.
    Lv Y; Lv Y; Wang Z; Yuan K; Zeng Y
    J Exp Clin Cancer Res; 2022 Jul; 41(1):224. PubMed ID: 35842651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting non-coding RNAs and N
    Wu L; Zhang Y; Ren J
    Biochem Pharmacol; 2024 May; 223():116153. PubMed ID: 38513741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of circular RNAs, transforming growth factor-β, and long noncoding RNAs in hepatocellular carcinoma.
    Shang W; Adzika GK; Li Y; Huang Q; Ding N; Chinembiri B; Rashid MS; Machuki JO
    Cancer Med; 2019 Nov; 8(15):6684-6699. PubMed ID: 31523930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
    He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
    Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noncoding RNA-mediated macrophage and cancer cell crosstalk in hepatocellular carcinoma.
    Zhou Z; Wang Z; Gao J; Lin Z; Wang Y; Shan P; Li M; Zhou T; Li P
    Mol Ther Oncolytics; 2022 Jun; 25():98-120. PubMed ID: 35506150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CLINICAL SIGNIFICANCE OF NONCODING RNA IN HEPATOCELLULAR CARCINOMA].
    Eguchi H; Doki Y; Mori M
    Nihon Geka Gakkai Zasshi; 2015 Nov; 116(6):366-9. PubMed ID: 26845888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-coding RNA methylation modifications in hepatocellular carcinoma: interactions and potential implications.
    Shi Q; Chu Q; Zeng Y; Yuan X; Wang J; Zhang Y; Xue C; Li L
    Cell Commun Signal; 2023 Dec; 21(1):359. PubMed ID: 38111040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncoding RNAs Serve as Diagnosis and Prognosis Biomarkers for Hepatocellular Carcinoma.
    Tan C; Cao J; Chen L; Xi X; Wang S; Zhu Y; Yang L; Ma L; Wang D; Yin J; Zhang T; John Lu Z
    Clin Chem; 2019 Jul; 65(7):905-915. PubMed ID: 30996051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things.
    Fang Y; Zhang X; Huang H; Zeng Z
    J Transl Med; 2023 Jun; 21(1):369. PubMed ID: 37286982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma.
    Liao W; Du J; Wang Z; Feng Q; Liao M; Liu H; Yuan K; Zeng Y
    Int J Cancer; 2022 Aug; 151(3):337-347. PubMed ID: 35460073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNAs in liver cancer: what we know in 2014.
    Zhao J; Greene CM; Gray SG; Lawless MW
    Expert Opin Ther Targets; 2014 Oct; 18(10):1207-18. PubMed ID: 25145388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
    Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
    Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.